| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | EARGO INC | $0 | – | -15,821,299 | -100.0% | -18.87% | – | |
| Exit | ROIVANT SCIENCES LTD | $0 | – | -12,639,920 | -100.0% | -81.13% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ROIVANT SCIENCES LTD | 4 | Q3 2023 | 81.1% |
| EARGO INC | 3 | Q3 2023 | 59.5% |
| EARGO INC | 1 | Q4 2022 | 76.9% |
View Patient Square Capital LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-13 |
View Patient Square Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.